Evidence map›Paper›PMID 27061024›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Designer Micelles Accelerate Flux Through Engineered Metabolism in E. coli and Support Biocompatible Chemistry.

Stephen Wallace, Emily P Balskus

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Micellar catalysis of the Suzuki Miyaura reaction using biogenic Pd nanoparticles fromGreen chemistry : an international journal and green chemistry resource : GC · 2021
    Article
  8. Article
  9. Review
  10. Microbial synthesis of vanillin from waste poly(ethylene terephthalate).Green chemistry : an international journal and green chemistry resource : GC · 2021
    Article
  11. Review
  12. A Screening Platform to Identify and Tailor Biocompatible Small-Molecule Catalysts.Chemistry (Weinheim an der Bergstrasse, Germany) · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Crossing boundaries: the importance of cellular membranes in industrial biotechnology.Journal of industrial microbiology & biotechnology · 2017
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen WallaceDepartment of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA, 02138, USA.ORCID 0000-0001-7691-2207
Emily P BalskusDepartment of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA, 02138, USA. balskus@chemistry.harvard.edu.

Funding

Biocompatible Chemistry for In Vivo Metabolite ModificationDP2GM105434 · NIGMS · HARVARD UNIVERSITY · PI BALSKUS, EMILY PATRICIA · 2012 to 2012
$2.5M
NIGMS NIH HHS DP2 GM105434
6 · The paper itself

Abstract

Synthetic biology has enabled the production of many value-added chemicals via microbial fermentation. However, the problem of low product titers from recombinant pathways has limited the utility of this approach. Methods to increase metabolic flux are therefore critical to the success of metabolic engineering. Here we demonstrate that vitamin E-derived designer micelles, originally developed for use in synthetic chemistry, are biocompatible and accelerate flux through a styrene production pathway in Escherichia coli. We show that these micelles associate non-covalently with the bacterial outer-membrane and that this interaction increases membrane permeability. In addition, these micelles also accommodate both heterogeneous and organic-soluble transition metal catalysts and accelerate biocompatible cyclopropanation in vivo. Overall, this work demonstrates that these surfactants hold great promise for further application in the field of synthetic biotechnology, and for expanding the types of molecules that can be readily accessed from renewable resources via the combination of microbial fermentation and biocompatible chemistry.

Indexed as

Metabolic EngineeringMicellesArabidopsisArabidopsis ProteinsBiocompatible MaterialsCarboxy-LyasesEscherichia coliFungal ProteinsGreen Chemistry TechnologyMicroscopy, Electron, TransmissionPhenylalaninePhenylalanine Ammonia-LyaseSaccharomyces cerevisiaeStyreneVitamin EArabidopsis ProteinsBiocompatible MaterialsCarboxy-LyasesFungal ProteinsMicellesphenylacrylic acid decarboxylasePhenylalaninePhenylalanine Ammonia-LyaseStyreneVitamin Ecatalysismetabolismmicellessustainable chemistrysynthetic biology

Identifiers

PMID27061024
PMCPMC4973394

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.